{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:11:13Z","timestamp":1790892673256,"version":"4.1.0"},"reference-count":84,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD097075"],"award-info":[{"award-number":["HD097075"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MIRNA"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>It is estimated that 2-4% of live births will have a birth defect (BD). The availability of bi-omarkers for the prenatal detection of BDs will facilitate early risk assessment, prompt medical interven-tion and ameliorating disease severity. miRNA expression levels are often found to be altered in many diseases. There is, thus, a growing interest in determining whether miRNAs, particularly extracellular miRNAs, can predict, diagnose, or monitor BDs. These miRNAs, typically encapsulated in exosomes, are released by cells (including those of the fetus and placenta) into the extracellular milieu, such as blood, urine, saliva and cerebrospinal fluid, thereby enabling interaction with target cells. Exosomal miRNAs are stable, protected from degradation, and retain functionality. The observation that placental and fetal miRNAs can be detected in maternal serum, provides a strong rationale for adopting miRNAs as non-invasive prenatal biomarkers for BDs. In this mini-review, we examine the current state of research in-volving the use of miRNAs as prognostic and diagnostic biomarkers for BD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211536611666220215123423","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T04:58:26Z","timestamp":1644987506000},"page":"2-11","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNAs as Biomarkers for Birth Defects"],"prefix":"10.2174","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-1070","authenticated-orcid":true,"given":"Ratnam S.","family":"Seelan","sequence":"first","affiliation":[{"name":"Department of Oral Immunology and Infectious Diseases, Division of Craniofacial Development and Anomalies, School of Dentistry, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Michele","family":"Pisano","sequence":"additional","affiliation":[{"name":"Department of Oral Immunology and Infectious Diseases, Division of Craniofacial Development and Anomalies, School of Dentistry, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-8103","authenticated-orcid":true,"given":"Robert M.","family":"Greene","sequence":"additional","affiliation":[{"name":"Department of Oral Immunology and Infectious Diseases, Division of Craniofacial Development and Anomalies, School of Dentistry, University of Louisville, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/OGX.0000000000000405","volume":"72","author":"Harris B.S.","year":"2017","unstructured":"Harris B.S.; Bishop K.C.; Kemeny H.R.; Walker J.S.; Rhee E.; Kuller J.A.; Risk factors for birth defects. Obstet Gynecol Surv 2017,72(2),123-135","journal-title":"Obstet Gynecol Surv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mrdd.20157","volume":"13","author":"Sherman S.L.","year":"2007","unstructured":"Sherman S.L.; Allen E.G.; Bean L.H.; Freeman S.B.; Epidemiology of down syndrome. Ment Retard Dev Disabil Res Rev 2007,13(3),221-227","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","volume":"22","author":"Malik I.","year":"2021","unstructured":"Malik I.; Kelley C.P.; Wang E.T.; Todd P.K.; Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat Rev Mol Cell Biol 2021,22(9),589-607","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/2211536608666190926114704","volume":"9","author":"Seelan R.S.","year":"2020","unstructured":"Seelan R.S.; Greene R.M.; Pisano M.M.; MicroRNAs as epigenetic targets of cigarette smoke during embryonic development. MicroRNA 2020,9(3),168-173","journal-title":"MicroRNA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1097\/AOG.0b013e318293d70b","volume":"121","author":"Hui L.","year":"2013","unstructured":"Hui L.; Wick H.C.; Edlow A.G.; Cowan J.M.; Bianchi D.W.; Global gene expression analysis of term amniotic fluid cell-free fetal RNA. Obstet Gynecol 2013,121(6),1248-1254","journal-title":"Obstet Gynecol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/SLA.0000000000001054","volume":"262","author":"Pereira-Terra P.","year":"2015","unstructured":"Pereira-Terra P.; Deprest J.A.; Kholdebarin R.; Unique tracheal fluid microRNA signature predicts response to FETO in patients with congenital diaphragmatic hernia. Ann Surg 2015,262(6),1130-1140","journal-title":"Ann Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0200229","DOI":"10.1371\/journal.pone.0200229","volume":"14","author":"Radhakrishna U.","year":"2019","unstructured":"Radhakrishna U.; Albayrak S.; Zafra R.; Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular Septal Defect (VSD). PLoS One 2019,14(3),e0200229","journal-title":"PLoS One"},{"key":"ref=8","first-page":"1","volume":"57","year":"2008","unstructured":"Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep Centers for Disease Control and Prevention (CDC)2008,57(1),1-5","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref=9","unstructured":"Boston\u2019s Children HospitalAvailable from:  (accessed\n7\/26\/2021)."},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"Ebert M.S.","year":"2012","unstructured":"Ebert M.S.; Sharp P.A.; Roles for microRNAs in conferring robustness to biological processes. Cell 2012,149(3),515-524","journal-title":"Cell"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"Bushati N.","year":"2007","unstructured":"Bushati N.; Cohen S.M.; microRNA functions. Annu Rev Cell Dev Biol 2007,23(1),175-205","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"Krol J.","year":"2010","unstructured":"Krol J.; Loedige I.; Filipowicz W.; The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010,11(9),597-610","journal-title":"Nat Rev Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/1873-3468.13067","volume":"592","author":"Creugny A.","year":"2018","unstructured":"Creugny A.; Fender A.; Pfeffer S.; Regulation of primary microRNA processing. FEBS Lett 2018,592(12),1980-1996","journal-title":"FEBS Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"Ha M.","year":"2014","unstructured":"Ha M.; Kim V.N.; Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014,15(8),509-524","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"Weber J.A.","year":"2010","unstructured":"Weber J.A.; Baxter D.H.; Zhang S.; The microRNA spectrum in 12 body fluids. Clin Chem 2010,56(11),1733-1741","journal-title":"Clin Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/icvts\/ivy033","volume":"27","author":"Girdauskas E.","year":"2018","unstructured":"Girdauskas E.; Petersen J.; Neumann N.; Evaluation of microribonucleic acids as potential biomarkers in the bicuspid aortic valve-associated aortopathy. Interact Cardiovasc Thorac Surg 2018,27(1),60-66","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/cells9020289","volume":"9","author":"Putkonen N.","year":"2020","unstructured":"Putkonen N.; Laiho A.; Ethell D.; Urine microRNA profiling displays miR-125a dysregulation in children with Fragile X syndrome. Cells 2020,9(2),289","journal-title":"Cells"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/humrep\/dey357","volume":"34","author":"Paoli D.","year":"2019","unstructured":"Paoli D.; Pecora G.; Pallotti F.; Cytological and molecular aspects of the ageing sperm. Hum Reprod 2019,34(2),218-227","journal-title":"Hum Reprod"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13402-014-0188-2","volume":"37","author":"Salazar C.","year":"2014","unstructured":"Salazar C.; Nagadia R.; Pandit P.; A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol (Dordr) 2014,37(5),331-338","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1261\/rna.036863.112","volume":"19","author":"Burgos K.L.","year":"2013","unstructured":"Burgos K.L.; Javaherian A.; Bomprezzi R.; Identification of extracellular miRNA in human cerebrospinal fluid by next-generation se-quencing. RNA 2013,19(5),712-722","journal-title":"RNA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"Valadi H.","year":"2007","unstructured":"Valadi H.; Ekstr\u00f6m K.; Bossios A.; Sj\u00f6strand M.; Lee J.J.; L\u00f6tvall J.O.; Exosome-mediated transfer of mRNAs and microRNAs is a novel mech-anism of genetic exchange between cells. Nat Cell Biol 2007,9(6),654-659","journal-title":"Nat Cell Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","volume":"22","author":"Chen X.","year":"2012","unstructured":"Chen X.; Liang H.; Zhang J.; Zen K.; Zhang C-Y.; Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 2012,22(3),125-132","journal-title":"Trends Cell Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"402475","DOI":"10.1155\/2014\/402475","volume":"2014","author":"Kamhieh-Milz J.","year":"2014","unstructured":"Kamhieh-Milz J.; Moftah R.F.H.; Bal G.; Differentially expressed microRNAs in maternal plasma for the noninvasive prenatal diagnosis of Down syndrome (trisomy 21). BioMed Res Int 2014,2014,402475","journal-title":"BioMed Res Int"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"Corsten M.F.","year":"2010","unstructured":"Corsten M.F.; Dennert R.; Jochems S.; Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010,3(6),499-506","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/ijms17111795","volume":"17","author":"Calvopina D.A.","year":"2016","unstructured":"Calvopina D.A.; Coleman M.A.; Lewindon P.J.; Ramm G.A.; Function and regulation of microRNAs and their potential as biomarkers in paediat-ric liver disease. Int J Mol Sci 2016,17(11),1795","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"Vickers K.C.","year":"2011","unstructured":"Vickers K.C.; Palmisano B.T.; Shoucri B.M.; Shamburek R.D.; Remaley A.T.; MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011,13(4),423-433","journal-title":"Nat Cell Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"Arroyo J.D.","year":"2011","unstructured":"Arroyo J.D.; Chevillet J.R.; Kroh E.M.; Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011,108(12),5003-5008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","volume":"7","author":"Gallo A.","year":"2012","unstructured":"Gallo A.; Tandon M.; Alevizos I.; Illei G.G.; The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012,7(3),e30679","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"Mitchell P.S.","year":"2008","unstructured":"Mitchell P.S.; Parkin R.K.; Kroh E.M.; Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008,105(30),10513-10518","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"Chen X.","year":"2008","unstructured":"Chen X.; Ba Y.; Ma L.; Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseas-es. Cell Res 2008,18(10),997-1006","journal-title":"Cell Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"Gilad S.","year":"2008","unstructured":"Gilad S.; Meiri E.; Yogev Y.; Serum microRNAs are promising novel biomarkers. PLoS One 2008,3(9),e3148","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","volume":"54","author":"Chim S.S.C.","year":"2008","unstructured":"Chim S.S.C.; Shing T.K.F.; Hung E.C.W.; Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008,54(3),482-490","journal-title":"Clin Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","volume":"141","author":"Lawrie C.H.","year":"2008","unstructured":"Lawrie C.H.; Gal S.; Dunlop H.M.; Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008,141(5),672-675","journal-title":"Br J Haematol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.mehy.2010.11.010","volume":"76","author":"Yu Z.","year":"2011","unstructured":"Yu Z.; Han S.; Hu P.; Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects. Med Hypotheses 2011,76(3),424-426","journal-title":"Med Hypotheses"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1373\/clinchem.2010.147660","volume":"56","author":"Miura K.","year":"2010","unstructured":"Miura K.; Miura S.; Yamasaki K.; Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 2010,56(11),1767-1771","journal-title":"Clin Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.ajog.2015.07.001","volume":"213","author":"Mitchell M.D.","year":"2015","unstructured":"Mitchell M.D.; Peiris H.N.; Kobayashi M.; Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol 2015,213(4)(Suppl.),S173-S181","journal-title":"Am J Obstet Gynecol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4172\/2167-7956.1000119","volume":"3","author":"Li X.","year":"2014","unstructured":"Li X.; Zhao Z.; MicroRNA biomarkers for early detection of embryonic malformations in pregnancy. J Biomol Res Ther 2014,3(3),119","journal-title":"J Biomol Res Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3978\/j.issn.2305-5839.2015.12.25","volume":"3","author":"Smith T.","year":"2015","unstructured":"Smith T.; Rajakaruna C.; Caputo M.; Emanueli C.; MicroRNAs in congenital heart disease. Ann Transl Med 2015,3(21),333","journal-title":"Ann Transl Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1471-2164-8-166","volume":"8","author":"Liang Y.","year":"2007","unstructured":"Liang Y.; Ridzon D.; Wong L.; Chen C.; Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007,8(1),166","journal-title":"BMC Genomics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2013.05.010","volume":"424","author":"Zhu S.","year":"2013","unstructured":"Zhu S.; Cao L.; Zhu J.; Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Clin Chim Acta 2013,424,66-72","journal-title":"Clin Chim Acta"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3892\/ijmm.2018.4008","volume":"43","author":"Chen T.","year":"2019","unstructured":"Chen T.; Li S.J.; Chen B.; Akt3 is a target of miR-29c-3p and serves an important function in the pathogenesis of congenital heart dis-ease. Int J Mol Med 2019,43(2),980-992","journal-title":"Int J Mol Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.biopha.2018.10.110","volume":"109","author":"Gu H.","year":"2019","unstructured":"Gu H.; Chen L.; Xue J.; Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects. Biomed Pharmacother 2019,109,823-830","journal-title":"Biomed Pharmacother"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/dbio.1999.9298","volume":"211","author":"Bruneau B.G.","year":"1999","unstructured":"Bruneau B.G.; Logan M.; Davis N.; Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999,211(1),100-108","journal-title":"Dev Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s00246-014-0901-y","volume":"35","author":"Wang F.","year":"2014","unstructured":"Wang F.; Yang X.Y.; Zhao J.Y.; miR-10a and miR-10b target the 3\u2032-untranslated region of TBX5 to repress its expression. Pediatr Cardiol 2014,35(6),1072-1079","journal-title":"Pediatr Cardiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12967-018-1411-0","volume":"16","author":"Song Y.","year":"2018","unstructured":"Song Y.; Higgins H.; Guo J.; Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart de-fects in children. J Transl Med 2018,16(1),42","journal-title":"J Transl Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.hjc.2018.06.004","volume":"61","author":"Tang P.","year":"2020","unstructured":"Tang P.; Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease. Hellenic J Cardiol 2020,61(1),26-30","journal-title":"Hellenic J Cardiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00246-016-1487-3","volume":"38","author":"Chen W.","year":"2017","unstructured":"Chen W.; Li S.; Circulating microRNA as a novel biomarker for pulmonary arterial hypertension due to congenital heart disease. Pediatr Cardiol 2017,38(1),86-94","journal-title":"Pediatr Cardiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00246-017-1607-8","volume":"38","author":"S\u00e1nchez-G\u00f3mez M.C.","year":"2017","unstructured":"S\u00e1nchez-G\u00f3mez M.C.; Garc\u00eda-Mej\u00eda K.A.; P\u00e9rez-D\u00edaz Conti M.; MicroRNAs association in the cardiac hypertrophy secondary to com-plex congenital heart disease in children. Pediatr Cardiol 2017,38(5),991-1003","journal-title":"Pediatr Cardiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","volume":"341","author":"Botto L.D.","year":"1999","unstructured":"Botto L.D.; Moore C.A.; Khoury M.J.; Erickson J.D.; Neural-tube defects. N Engl J Med 1999,341(20),1509-1519","journal-title":"N Engl J Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1093\/hmg\/ddp347","volume":"18","author":"Greene N.D.","year":"2009","unstructured":"Greene N.D.; Stanier P.; Copp A.J.; Genetics of human neural tube defects. Hum Mol Genet 2009,18(R2),R113-R129","journal-title":"Hum Mol Genet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2012.07812.x","volume":"122","author":"Gu H.","year":"2012","unstructured":"Gu H.; Li H.; Zhang L.; Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. J Neurochem 2012,122(3),641-649","journal-title":"J Neurochem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"Mai C.T.","year":"2019","unstructured":"Mai C.T.; Isenburg J.L.; Canfield M.A.; National population-based estimates for major birth defects, 2010-2014. Birth Defects Res 2019,111(18),1420-1435","journal-title":"Birth Defects Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4103\/1673-5374.179070","volume":"11","author":"Qin P.","year":"2016","unstructured":"Qin P.; Li L.; Zhang D.; Altered microRNA expression profiles in a rat model of spina bifida. Neural Regen Res 2016,11(3),502-507","journal-title":"Neural Regen Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14767058.2015.1119114","volume":"30","author":"Qin P.","year":"2017","unstructured":"Qin P.; Li L.; Zhang D.; Preliminary investigation of methylation status of microRNA-124a in spinal cords of rat fetuses with congenital spina bifida. J Matern Fetal Neonatal Med 2017,30(1),23-28","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/nmo.12776","volume":"28","author":"Rogers J.M.","year":"2016","unstructured":"Rogers J.M.; Search for the missing lncs: Gene regulatory networks in neural crest development and long non-coding RNA biomarkers of Hirschsprung\u2019s disease. Neurogastroenterol Motil 2016,28(2),161-166","journal-title":"Neurogastroenterol Motil"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/jcmm.12348","volume":"18","author":"Tang W.","year":"2014","unstructured":"Tang W.; Li H.; Tang J.; Specific serum microRNA profile in the molecular diagnosis of Hirschsprung\u2019s disease. J Cell Mol Med 2014,18(8),1580-1587","journal-title":"J Cell Mol Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10815-015-0429-y","volume":"32","author":"Lim J.H.","year":"2015","unstructured":"Lim J.H.; Lee D.E.; Kim S.Y.; MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21. J Assist Reprod Genet 2015,32(5),827-837","journal-title":"J Assist Reprod Genet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4274\/balkanmedj.2017.0511","volume":"35","author":"Karaca E.","year":"2018","unstructured":"Karaca E.; Aykut A.; Ert\u00fcrk B.; MicroRNA expression profile in the prenatal amniotic fluid samples of pregnant women with Down syndrome. Balkan Med J 2018,35(2),163-166","journal-title":"Balkan Med J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/pd.4861","volume":"36","author":"Svobodov\u00e1 I","year":"2016","unstructured":"Svobodov\u00e1 I; Korabe\u010dn\u00e1 M.; Calda P.; Differentially expressed miRNAs in trisomy 21 placentas. Prenat Diagn 2016,36(8),775-784","journal-title":"Prenat Diagn"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41598-018-35876-5","volume":"9","author":"Zbucka-Kretowska M.","year":"2019","unstructured":"Zbucka-Kretowska M.; Niemira M.; Paczkowska-Abdulsalam M.; Prenatal circulating microRNA signatures of foetal Down syndrome. Sci Rep 2019,9(1),2394","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molcel.2011.05.006","volume":"42","author":"Muddashetty R.S.","year":"2011","unstructured":"Muddashetty R.S.; Nalavadi V.C.; Gross C.; Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell 2011,42(5),673-688","journal-title":"Mol Cell"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11920-021-01225-z","volume":"23","author":"Fiksinski A.M.","year":"2021","unstructured":"Fiksinski A.M.; Schneider M.; Zinkstok J.; Baribeau D.; Chawner S.J.R.A.; Vorstman J.A.S.; Neurodevelopmental trajectories and psychiatric mor-bidity: Lessons learned from the 22q11.2 deletion syndrome. Curr Psychiatry Rep 2021,23(3),13","journal-title":"Curr Psychiatry Rep"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e103884","DOI":"10.1371\/journal.pone.0103884","volume":"9","author":"Sellier C.","year":"2014","unstructured":"Sellier C.; Hwang V.J.; Dandekar R.; Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syn-drome. PLoS One 2014,9(8),e103884","journal-title":"PLoS One"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.biopha.2016.05.033","volume":"82","author":"Zou J.","year":"2016","unstructured":"Zou J.; Li J.; Li J.; Ji C.; Li Q.; Guo X.; Expression profile of plasma microRNAs in nonsyndromic cleft lip and their clinical significance as biomarkers. Biomed Pharmacother 2016,82,459-466","journal-title":"Biomed Pharmacother"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"18929","DOI":"10.18632\/oncotarget.24838","volume":"9","author":"Grassia V.","year":"2018","unstructured":"Grassia V.; Lombardi A.; Kawasaki H.; Salivary microRNAs as new molecular markers in cleft lip and palate: A new frontier in mo-lecular medicine. Oncotarget 2018,9(27),18929-18938","journal-title":"Oncotarget"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jama.2017.21896","volume":"319","author":"May P.A.","year":"2018","unstructured":"May P.A.; Chambers C.D.; Kalberg W.O.; Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA 2018,319(5),474-482","journal-title":"JAMA"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/pd.5474","volume":"39","author":"Goetzl L.","year":"2019","unstructured":"Goetzl L.; Darbinian N.; Merabova N.; Noninvasive assessment of fetal central nervous system insult: Potential application to prenatal diag-nosis. Prenat Diagn 2019,39(8),609-615","journal-title":"Prenat Diagn"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/humu.22977","volume":"37","author":"Verstraeten A.","year":"2016","unstructured":"Verstraeten A.; Alaerts M.; Van Laer L.; Loeys B.; Marfan syndrome and related disorders: 25 years of gene discovery. Hum Mutat 2016,37(6),524-531","journal-title":"Hum Mutat"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12967-018-1429-3","volume":"16","author":"Abu-Halima M.","year":"2018","unstructured":"Abu-Halima M.; Kahraman M.; Henn D.; Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome. J Transl Med 2018,16(1),60","journal-title":"J Transl Med"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1055\/s-0037-1604083","volume":"66","author":"Abu-Halima M.","year":"2018","unstructured":"Abu-Halima M.; Ludwig N.; R\u00e4dle-Hurst T.; Characterization of micro-RNA profile in the blood of patients with Marfan\u2019s syndrome. Thorac Cardiovasc Surg 2018,66(1),116-124","journal-title":"Thorac Cardiovasc Surg"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MPG.0b013e318244148b","volume":"54","author":"Hand N.J.","year":"2012","unstructured":"Hand N.J.; Horner A.M.; Master Z.R.; MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experi-mental biliary atresia. J Pediatr Gastroenterol Nutr 2012,54(2),186-192","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MPG.0b013e318264e648","volume":"55","author":"Zahm A.M.","year":"2012","unstructured":"Zahm A.M.; Hand N.J.; Boateng L.A.; Friedman J.R.; Circulating microRNA is a biomarker of biliary atresia. J Pediatr Gastroenterol Nutr 2012,55(4),366-369","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MPG.0000000000001194.","volume":"63","author":"Peng X.","year":"2016","unstructured":"Peng X.; Yang L.; Liu H.; Identification of circulating microRNAs in biliary atresia by next-generation sequencing. J Pediatr Gastroenterol Nutr 2016,63(5),518-523","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"21084","DOI":"10.1038\/srep21084","volume":"6","author":"Dong R.","year":"2016","unstructured":"Dong R.; Shen Z.; Zheng C.; Chen G.; Zheng S.; Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diag-nostic biomarkers for biliary atresia. Sci Rep 2016,6(1),21084","journal-title":"Sci Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12967-016-0955-0","volume":"14","author":"Jovanovic I.","year":"2016","unstructured":"Jovanovic I.; Zivkovic M.; Kostic M.; Transcriptome-wide based identification of miRs in congenital anomalies of the kidney and uri-nary tract (CAKUT) in children: The significant upregulation of tissue miR-144 expression. J Transl Med 2016,14(1),193","journal-title":"J Transl Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yjmcc.2019.04.022","volume":"132","author":"Tobin S.W.","year":"2019","unstructured":"Tobin S.W.; Alibhai F.J.; Lee M.M.; Novel mediators of aneurysm progression in bicuspid aortic valve disease. J Mol Cell Cardiol 2019,132,71-83","journal-title":"J Mol Cell Cardiol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12967-017-1176-x","volume":"15","author":"Mart\u00ednez-Micaelo N.","year":"2017","unstructured":"Mart\u00ednez-Micaelo N.; Beltr\u00e1n-Deb\u00f3n R.; Baiges I.; Faiges M.; Alegret J.M.; Specific circulating microRNA signature of bicuspid aortic valve disease. J Transl Med 2017,15(1),76","journal-title":"J Transl Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fphys.2017.00648","volume":"8","author":"Mart\u00ednez-Micaelo N.","year":"2017","unstructured":"Mart\u00ednez-Micaelo N.; Beltr\u00e1n-Deb\u00f3n R.; Aragon\u00e9s G.; Faiges M.; Alegret J.M.; MicroRNAs clustered within the 14q32 locus are associated with endothelial damage and microparticle secretion in bicuspid aortic valve disease. Front Physiol 2017,8,648","journal-title":"Front Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijcard.2018.10.005","volume":"273","author":"Gallo A.","year":"2018","unstructured":"Gallo A.; Agnese V.; Coronnello C.; On the prospect of serum exosomal miRNA profiling and protein biomarkers for the diagnosis of ascending aortic dilatation in patients with bicuspid and tricuspid aortic valve. Int J Cardiol 2018,273,230-236","journal-title":"Int J Cardiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"110896","DOI":"10.1016\/j.nut.2020.110896","volume":"81","author":"Luo W.","year":"2021","unstructured":"Luo W.; Dong Y.; Hu T.; 25(OH)D status and expression of miR-140 in the serum of patients with developmental dysplasia of the hip. Nutrition 2021,81,110896","journal-title":"Nutrition"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"10735","DOI":"10.1038\/s41598-018-29153-8","volume":"8","author":"Herrera-Rivero M.","year":"2018","unstructured":"Herrera-Rivero M.; Zhang R.; Heilmann-Heimbach S.; Circulating microRNAs are associated with pulmonary hypertension and devel-opment of chronic lung disease in congenital diaphragmatic hernia. Sci Rep 2018,8(1),10735","journal-title":"Sci Rep"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3390\/cells9081867","volume":"9","author":"Chen S.D.","year":"2020","unstructured":"Chen S.D.; Pan H.Y.; Huang J.B.; Circulating microRNAs from serum exosomes may serve as a putative biomarker in the diagnosis and treatment of patients with focal cortical dysplasia. Cells 2020,9(8),1867","journal-title":"Cells"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13293-020-00327-2","volume":"11","author":"Salem N.A.","year":"2020","unstructured":"Salem N.A.; Mahnke A.H.; Wells A.B.; Association between fetal sex and maternal plasma microRNA responses to prenatal alcohol ex-posure: Evidence from a birth outcome-stratified cohort. Biol Sex Differ 2020,11(1),51","journal-title":"Biol Sex Differ"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1038\/s41467-021-23497-y","volume":"12","author":"Cai S.","year":"2021","unstructured":"Cai S.; Pataillot-Meakin T.; Shibakawa A.; Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum. Nat Commun 2021,12(1),3515","journal-title":"Nat Commun"}],"container-title":["MicroRNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211536611666220215123423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201144\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211536611666220215123423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:48:00Z","timestamp":1693162080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201144\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211536611666220215123423","relation":{},"ISSN":["2211-5366"],"issn-type":[{"value":"2211-5366","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}